Saint Joseph's University, Philadelphia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Saint Joseph's University, Philadelphia sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Saint Joseph's University, Philadelphia: 4 sponsored US clinical trials, 1 recruiting.
Saint Joseph's University, Philadelphia sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Sleep Disturbance, with 1 trials.
Upper-quartile sponsor footprint
Saint Joseph's University, Philadelphia sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Combined Functional Electrical and Transcranial Direct Current Stimulation for Foot Drop
NCT07592221
Effect of Telehealth Mindfulness on Sleep and Anxiety in Acquired Brain Injury Population
NCT06717399
Impact of Bedtime Routines on Sleep and Development in Toddlers
NCT04592172
Impact of Bed Provision and Sleep Education
NCT04536766
Therapeutic Areas
What is open in the Saint Joseph's University, Philadelphia pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Sleep Disturbance (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Saint Joseph's University, Philadelphia: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Saint Joseph's University, Philadelphia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Saint Joseph's University, Philadelphia page
4 registered trials is a research-attention snapshot, not an endorsement of Saint Joseph's University, Philadelphia or any single study.
- 1 of Saint Joseph's University, Philadelphia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Sleep Disturbance is the condition Saint Joseph's University, Philadelphia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sleep Disturbance trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Saint Joseph's University, Philadelphia pipeline card: 4 registered trials from official public datasets.Report a data error.